CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Trends Analyst Outlook Journalist POV

43 hedge funds and large institutions have $14.9M invested in Cellectar Biosciences in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

39% less capital invested

Capital invested by funds: $24.2M → $14.9M (-$9.35M)

Holders
43
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$275K
2
+$218K
3
+$181K
4
State Street
State Street
Massachusetts
+$176K
5
QI
QS Investors
New York
+$170K

Top Sellers

1
-$3.52M
2
-$976K
3
-$484K
4
Millennium Management
Millennium Management
New York
-$397K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$350K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$32K
27
$28K
28
$22K
29
$20K
30
$18K
31
$17K
32
$17K
33
$14K
34
$12K
35
$12K
36
$9K
37
$9K
38
$7K
39
$4K
40
$3K
41
$2K
42
$1K
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3